Last year, we examined Alzheimer’s disease in detail. In June 2021, there seemed to be a treatment breakthrough. However, as of now, we see very disturbing news about a new Alzheimer’s drug.…
Let us consider diabetes – insulin – and cancer. As we approach the 100th anniversary of the innovation of insulin. This anniversary is important due to the relationship between diabetes and cancer.…
We look at the current state of hospital price transparency. It is still not good.
This article builds on these two posts:
This material is reproduced from “Hospital Prices Must Now Be Transparent.…
Read more
As we have noted several times, the National Cancer Institute (NCI) is vital in the fight against cancer. And one of its key initiatives is the PREVENT Cancer Preclinical Drug Development Program.…
During the existence of this blog, we have written a lot about cancer research. And the many resulting advances in healthcare. Including for children. Here, we examine the expansion of St.…
As previously noted, the giants of technology are ramping up their healthcare efforts. Especially the ones not grounded in the healthcare industry. Let us consider big tech takes on healthcare.…
There is greater scrutiny of health-care pricing than ever before. Last year, we reviewed the new rules requiring more transparency. Yet, as of April 2021, we study how hospitals try to minimize price transparency.…
